|
- Sandoz - the leading name in generic and biosimilar
Sandoz is the global leader in generic and biosimilar medicines Our Purpose is to pioneer access to medicines for patients globally
- Careers - Sandoz
Becoming an independent listed company in October 2023 was a pivotal moment for Sandoz that started us on an exciting multi-year journey of transformation and growth Together, we are shaping the future of Sandoz
- Sandoz: BioPharmaceutical Company | Sandoz US
Discover how Sandoz is transforming healthcare with high-quality, affordable medicines and biosimilars for people around the world
- About Sandoz
It’s a rich story of pioneers who paved the way for extraordinary progress in healthcare The Sandoz brand dates back to 1886 and we can look back on a wide range of pioneering scientific breakthroughs Here are some of the highlights of the Sandoz heritage
- Sandoz 2024 Integrated Annual Report
At Sandoz, we provide more than 900 million patient treatments annually, leading to USD 19 billion savings per year for healthcare systems in Europe and the US alone, and generating a total social impact estimated at USD 400 billion annually
- Integrated Report - sandoz-com. cms. sandoz. com
Sandoz today is the leading global provider of of-patent medicines (biosimilars and generics), which account overall for approximately 80% of medicines used worldwide at a fraction of the total cost
- Investors | Sandoz
Investor Relations Sandoz serves a clear Purpose: pioneering access for patients We provide around 1,300 products to 100+ countries In 2024, that meant we delivered more than 900 million patient treatments
- sandoz-ca. cms. sandoz. com
Read this carefully before you start taking Sandoz Timolol and each time you get a refill This leaflet is a summary and will not tell you everything about this drug
|
|
|